Inventiva S.A.
IVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001756594
No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $319.5M in total; no superinvestor holds it.
Other share classesIVEVF
Q1 2026 vs. Q4 2025
How the institutions holding Inventiva S.A. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 53 | 65 | +12 |
| Shares | 46.7M | 52.4M | +5.65M (+12.1%) |
| Value | $217.2M | $290.4M | +$73.2M (+33.7%) |
New holders (22)
Institutions that held Inventiva S.A. at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (10)
Institutions that held Inventiva S.A. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Alyeska Investment Group, L.P. | 500,000 | $2.33M |
| StemPoint Capital LP | 467,242 | $2.17M |
| Saturn V Capital Management LLC | 283,166 | $1.32M |
| Yiheng Capital Management, L.P. | 255,915 | $1.19M |
| Eventide Asset Management, LLC | 250,000 | $1.16M |
| Superstring Capital Management LP | 100,000 | $465.0K |
| AQR Capital Management LLC | 10,000 | $46.5K |
| Creative Planning | 10,000 | $46.5K |
| Bank of America Corp | 44 | $205 |
| Citigroup Inc | 1 | $5 |